Relation of luteinizing hormone levels to body mass index in premenopausal women

Fertility and Sterility

Volumn 69, Issue 3 SUPPL. 2, 1998, Pages 500-504

  Bohlke, Kari ^a,c,d   Cramer, Daniel W ^a,b,c,d   Barbieri, Robert L ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Department of Obstetrics and Gynecology ^*  (United States)

^d Obstetrics and Gynecology Epidemiology Center   (United States)

Author keywords

Body mass index; FSH; LH; Premenopausal

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY POLYCYSTIC DISEASE; PREMENOPAUSE; PRIORITY JOURNAL;

ADULT; BODY MASS INDEX; CONTRACEPTIVES, ORAL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MIDDLE AGED; PREMENOPAUSE;

EID: 0031953392     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0015-0282(97)00551-7     Document Type: Article

References (21)

1. Laatikainen T, Tulenheimo A, Andersson B, Karkkainen J. Obesity, serum steroid levels, and pulsatile gonadotropin secretion in polycystic ovarian disease. Eur J Obstet Gynecol Reprod Biol 1983;15:45-53.
2. Cramer DW, Barbieri RL, Muto MG, Kelly A, Brucks JP, Harlow BL. Characteristics of women with a family history of ovarian cancer. II. Follicular phase hormone levels. Cancer 1994;74:1318-22.
3. Barbieri RL, Gao X, Xu H, Cramer DW. Effects of previous use of oral contraceptives on early follicular phase follicle-stimulating hormone. Fertil Steril 1995;64:689-92.
4. Cramer DW, Barbieri RL, Xu H, Reichardt JKY. Determinants of basal follicle-stimulating hormone levels. J Clin Endocrinol Metab 1194;79:1105-9.
5. Paradisi R, Venturoli S, Pasquali R, Capelli M, Porcu E, Fabbri R, et al. Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease. J Endocrinol Invest 1986;9:139-44.
6. Dunaif A, Mandeli J, Fluhr H, Dobrjansky A. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. J Clin Endocrinol Metab 1988;66:131-39.
7. Conway GS, Jacobs HS, Holley JMP, Wass JAH. Effects of luteinizing hormone, insulin, insulin-like growth factor-1 and insulin-like growth factor small binding protein 1 in the polycystic ovary syndrome. Clin Endocrinol (Oxf) 1990;33:593-603.
8. Anttila L, Ding YQ, Ruutiainen K, Erkkola R, Irjala K, Huhtaniemi I. Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease. Fertil Steril 1991;55:1057-61.
9. Dale PO, Tanbo T, Vaaler S, Abyholm T. Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovary syndrome: evidence of two distinct populations. Fertil Steril 1992;58:487-91.
10. Holte J, Bergh T, Gennarelli G, Wide L. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Clin Endocrinol 1994;41:473-81.
11. Morales AJ, Laughlin GA, Butzow T, Maheshwari H, Baumann G, Yen SSC. Insulin, somatotropic, and luteinizing hormone axes in non-obese and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab 1996;81:2854-64.
12. Tropeano G, Vuolo IP, Lucisano A, Liberale I, Barini A, Carfagna P, et al. Gondotropin levels in women with polycystic ovary syndrome: the relationship to body weight and insulin levels. J Endocrinol Invest 1996;19:139-45.
13. Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schenfeld D, et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997;82:2248-56.
14. Reyes FI, Winter JS, Faiman C. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follicle-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Am J Obstet Gynecol 1977;129:557-64.
15. Lee SJ, Lenton EA, Sexton L, Cooke ID. The effect of age on the cyclical patterns of plasma LH, FSH, oestradiol and progesterone in women with regular menstrual cycles. Hum Reprod 1988;3:851-5.
16. Stewart AL. The reliability and validity of self-reported weight and height. J Chron Dis 1982;35:295-309.
17. Palta M, Prineas RJ, Berman R, Hannan P. Comparison of self-reported and measured height and weight. Am J Epidemiol 1982;115:223-30.
18. Stewart AW, Jackson RT, Ford MA, Beaglehole R. Underestimation of relative weight by use of self-reported height and weight. Am J Epidemiol 1987;125:122-6.
19. Grulet H, Hecart AC, Delmer B, Gross A, Sulmont V, Leutenegger M, et al. Roles of LH and insulin resistance in non-obese and obese polycystic ovary syndrome. Clin Endocrinol (Oxf) 1993;38:621-6.
20. Pasquali R, Casimirri F, Venturoli S, Paradisi R, Mattoli L, Capelli M, et al. Insulin resistance in patients with polycystic ovaries: its relationship to body weight and androgen levels. Acta Endocrinol (Copenh) 1983;104:110-6.
21. Buyalos RP, Geffner ME, Watanabe RM, Bergman RN, Gornbein JA, Judd HL. The influence of luteinizing hormone and insulin on sex steroids and sex hormone-binding globulin in the polycystic ovarian syndrome. Fertil Steril 1993;60:626-33.